Cost, Insurance Reimbursement Complicating Rollout Of RSV Antibody

CBS News (10/11, Brand, M. Moniuszko) reports, “The CDC and FDA have approved the Beyfortus antibody shot, from drugmakers AstraZeneca and Sanofi, to prevent respiratory syncytial virus in babies from birth to 8 months old, or in children up to 24 months...